Home
Goodwin Procter LLP
Emma Murray
Emma Murray
Goodwin Procter LLP
FDA Approves New Indication For AstraZeneca And Daiichi Sankyo's Cancer Drug ENHERTU
15 Apr 2024 | United States
FDA Approves Sandoz Denosumab Biosimilars
18 Mar 2024 | United States
Biocon Settles With Janssen, Securing U.S. Market Entry Date For Ustekinumab Biosimilar
15 Mar 2024 | United States
Biocon Settles With Bayer And Regeneron, Securing Canada Market Entry Date For Aflibercept Biosimilar
15 Mar 2024 | United States
Biosimilar Regulatory Updates
12 Feb 2024 | United States
Year In Review: Top Regulatory Developments Of 2023
02 Feb 2024 | United States
Updates On Aflibercept BPCIA Litigation
10 Jan 2024 | United States
Contact Details
New York
Email Website
New York
United States

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.